基于CRISPR/Cas的电化学生物传感器用于人类免疫缺陷病毒-1的核酸无放大检测到原子级
Lingxuan Qu1, Lingyi Meng2, Xilin Sun1
1Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, China.
ACS sensors
|August 4, 2025
概括
一个新的CRISPR/Cas13a电化学传感器为现场使用提供了灵敏,低成本的HIV-1检测. 这种无放大方法使得可以在临床检测和监测患者的耐药性.
科学领域:
- 生物技术是生物技术.
- 分子诊断学 分子诊断学
- 生物传感器是一种生物传感器.
背景情况:
- 发展中国家和医疗保健机构需要便携式,灵敏且负担得起的核酸检测仪,用于HIV-1查和病毒载量监测.
- 现有的方法往往缺乏必要的灵敏度,可移植性或成本效益,以实现广泛的现场应用.
研究的目的:
- 开发一种基于CRISPR/Cas13a的新型电化学传感平台,用于灵敏且经济高效的HIV-1检测.
- 为了实现便携式,无放大点的护理测试 (POCT) 艾滋病毒-1监测和患者管理.
主要方法:
- 采用了CRISPR/Cas13a系统,使用了多个结合crRNAs策略.
- 一个电化学检测平台的设计是基于离子电流校正通过一个有孔的阳极胺膜与ssRNA基质功能化.
- 被激活的Cas13a对ssRNA的分裂改变了离子流,使得目标HIV-1序列的检测成为可能.
主要成果:
- 开发的平台证明了HIV-1的可行性和超敏感检测.
- 在血清样本中,HIV-1的临床样本检测极限达到60副本/μL.
- 无放大方法的灵敏度比非放大光基核酸策略高一个数量级.
结论:
- 该CRISPR/Cas13a电化学传感器为HIV-1检测提供了一个简单,经济高效和高度敏感的解决方案.
- 这种POCT技术适用于发展中国家的现场查和艾滋病毒-1患者药物耐药性的自我监测.
- 该平台的适应性允许潜在扩展到检测其他基于RNA的病原体.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


